Quick Answer
Renalytix plc reported Stockholders Equity of -$7.85 million for fiscal year 2024.
Renalytix plc Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2024 | -$7.85M | -212.7% |
| 2023 | $6.97M | -77.2% |
| 2022 | $30.61M | -57.2% |
| 2021 | $71.46M | +349.1% |
| 2020 | $15.91M | +86.1% |
| 2019 | $8.55M | +1803.4% |
| 2018 | -$502.0K | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2024 | -$11.32M | -659.2% | -44.1% |
| June 30, 2024 | -$7.85M | -212.7% | +29.3% |
| March 31, 2024 | -$11.11M | -161.4% | -39.7% |
| December 31, 2023 | -$7.96M | -189.5% | -433.6% |
| September 30, 2023 | -$1.49M | -107.9% | -121.4% |
| June 30, 2023 | $6.97M | -77.2% | -61.5% |
| March 31, 2023 | $18.10M | — | +103.7% |
| December 31, 2022 | $8.88M | — | -52.8% |
- Renalytix plc showed a decrease of -212.7% in Stockholders Equity compared to the prior fiscal year.
- Over the 2018–2024 period, Renalytix plc’s stockholders equity has declined by 1464.5% (from -$502.0 thousand to -$7.85 million).
- The most recent figure is from Renalytix plc’s fiscal year 2024 report (Form 10-K), filed with the SEC on September 30, 2024.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: